Park Ha Biological Technology is trading 11.34% up now at $2.65 after the company disclosed a $2.97 million private placement that closed three days earlier.

  • The financing supplied fresh capital but renewed concerns about continued dilution, the clearest company-specific catalyst identified for the September 14, 2026 move.
  • Trading is active during the open session, but no reliable volume figure was available. Confidence is medium because coverage is limited; MarketWatch also reported the September financing as a major recent development.